Biogen MS Pill Tecfidera Gains U.S. Approval

March 27 (Bloomberg) -- Biogen Idec, the maker of multiple sclerosis drugs Avonex and Tysabri, won U.S. approvalfor its first pill for the disease, Tecfidera. Adam Johnson reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)
Canada's Harper on Economy, Keystone XL, Elections
41:39 - Canadian Prime Minister Stephen Harper talks about the Canadian economy, the government's fiscal and trade policies, the Keystone XL pipeline project and the outlook for Canadian elections on Oct. 19. Harper speaks with Bloomberg's Theophilos Argitis at his office in Ottawa. (Source: Bloomberg)
  • Are the Odds Stacked Against Tom Brady?
  • Now You Can Pay for College With Frequent Flyer Miles
  • Oil Rises After U.S. Crude Stockpiles Decline